Clifton E Barry Iii
Overview
Explore the profile of Clifton E Barry Iii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chengalroyen M, Mason M, Borsellini A, Tassoni R, Abrahams G, Lynch S, et al.
ACS Infect Dis
. 2022 Feb;
8(3):612-625.
PMID: 35143160
Natural products provide a rich source of potential antimicrobials for treating infectious diseases for which drug resistance has emerged. Foremost among these diseases is tuberculosis. Assessment of the antimycobacterial activity...
2.
Sakai S, Lora N, Kauffman K, Dorosky D, Oh S, Namasivayam S, et al.
Mucosal Immunol
. 2021 Jun;
14(5):1055-1066.
PMID: 34158594
Targeting MAIT cells holds promise for the treatment of different diseases and infections. We previously showed that treatment of Mycobacterium tuberculosis infected mice with 5-OP-RU, a major antigen for MAIT...
3.
Zhao G, Kosek D, Liu H, Ohlemacher S, Blackburne B, Nikolskaya A, et al.
J Am Chem Soc
. 2021 May;
143(21):8056-8068.
PMID: 34028251
Among the ribosomally synthesized and post-translationally modified peptide (RiPP) natural products, "graspetides" (formerly known as microviridins) contain macrocyclic esters and amides that are formed by ATP-grasp ligase tailoring enzymes using...
4.
Kolbe K, Bell A, Prosser G, Assmann M, Yang H, Forbes H, et al.
Front Microbiol
. 2020 Dec;
11:591866.
PMID: 33362741
resides in the lungs in various lesion types with unique microenvironmental conditions. This diversity is in line with heterogeneous disease progression and divergent drug efficiency. Fluorescent reporter strains can be...
5.
6.
Dong Y, Wang H, Pike A, Cochrane S, Hamedzadeh S, Wyszynski F, et al.
Cell
. 2018 Nov;
175(4):1045-1058.e16.
PMID: 30388443
Protein N-glycosylation is a widespread post-translational modification. The first committed step in this process is catalysed by dolichyl-phosphate N-acetylglucosamine-phosphotransferase DPAGT1 (GPT/E.C. 2.7.8.15). Missense DPAGT1 variants cause congenital myasthenic syndrome and...
7.
Chen R, Via L, Dodd L, Walzl G, Malherbe S, Loxton A, et al.
Gates Open Res
. 2018 Mar;
1:9.
PMID: 29528048
Trial Registration: NCT02821832.
8.
Gengenbacher M, Duque-Correa M, Kaiser P, Schuerer S, Lazar D, Zedler U, et al.
Sci Rep
. 2017 Aug;
7(1):8853.
PMID: 28821804
During active TB in humans a spectrum of pulmonary granulomas with central necrosis and hypoxia exists. BALB/c mice, predominantly used in TB drug development, do not reproduce this complex pathology...
9.
Esmail H, Lai R, Lesosky M, Wilkinson K, Graham C, Coussens A, et al.
Nat Med
. 2016 Sep;
22(10):1090-1093.
PMID: 27595321
Tuberculosis is classically divided into states of latent infection and active disease. Using combined positron emission and computed tomography in 35 asymptomatic, antiretroviral-therapy-naive, HIV-1-infected adults with latent tuberculosis, we identified...
10.
Eum S, Kong J, Jeon B, Cho S, Kim J, Via L, et al.
J Med Case Rep
. 2010 May;
4:156.
PMID: 20504347
Introduction: Pulmonary ossification has been rarely observed in pulmonary fibrosis and in some chronic respiratory diseases such as chronic obstructive pulmonary disease. We report here a metaplastic ossification in the...